Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
22.6%
% of PTH's 53 holdings also in SBIO
13.5%
% of SBIO's 89 holdings also in PTH
Overlap by Weight
Sector Drift (PTH minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PTH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
KRYSTAL BIOTECH, INC. | 2.0% | 3.4% | 2.0% |
|
CORCEPT THERAPEUTICS INC | 1.9% | 4.2% | 1.9% |
|
CRINETICS PHARMACEUTICALS INC | 1.8% | 3.1% | 1.8% |
|
APOGEE THERAPEUTICS, INC. | 1.4% | 1.5% | 1.4% |
|
PROTAGONIST THERAPEUTICS, INC. | 1.4% | 1.7% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
PTH Overweight Relative to SBIO
|
ELI LILLY & CO | 4.7% |
|
NATERA INC | 4.3% |
|
INSMED INC | 4.3% |
|
VAXCYTE, INC. | 3.9% |
|
TENET HEALTHCARE CORP | 3.6% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
HCA HOLDINGS INC | 2.9% |
|
ADMA BIOLOGICS, INC. | 2.8% |
|
ABBVIE INC | 2.6% |
|
CATALYST PHARMACEUTICAL PART | 2.6% |
PTH Underweight Relative to SBIO
 |
ALKERMES PLC | -3.6% |
|
ARCELLX, INC. | -3.2% |
|
AVIDITY BIOSCIENCES INC | -2.7% |
|
PTC THERAPEUTICS INC | -2.5% |
|
CORCEPT THERAPEUTICS INC | -2.2% |
 |
MERUS N.V. | -2.2% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.1% |
|
ACADIA PHARMACEUTICALS INC | -2.1% |
|
VERICEL CORPORATION | -2.0% |
|
AMICUS THERAPEUTICS INC | -2.0% |